Journals / Clinical and Experimental Health Sciences / 2011 / Cilt: 1 - Sayı: 1

Behçet’s disease

Behçet hastalığı

Pages
65–73
Publication Date
2014-01-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review updates the BD in point of epidemiology, clinical symptoms, diagnosis, prognosis and etiopathology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Behcet’s Disease (BD) is a chronic multisystem vascularinflammatory disorder, firstly described by the Turkish dermatologist Hulusi Behçet (1889-1948) in 1937.
📊
Key Findings & Data:It is thought to be auto-immune and characterized by attacks of oral and genital ulcers, arthritis, cutaneous lesions, ocular lesions, involvement of the gastrointestinal tract and central nervous system.
💡
Conclusion & Impact:This review updates the BD in point of epidemiology, clinical symptoms, diagnosis, prognosis and etiopathology.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Behçet hastalığı · epidemiyoloji · etyopatogenez

Abstract

Behcet’s Disease (BD) is a chronic multisystem vascularinflammatory disorder, firstly described by the Turkish dermatologist Hulusi Behçet (1889-1948) in 1937. It is thought to be auto-immune and characterized by attacks of oral and genital ulcers, arthritis, cutaneous lesions, ocular lesions, involvement of the gastrointestinal tract and central nervous system. However the etiology of BD is still unknown, infectious, psychological, genetic and immunological factors can be counted as the possible etiologic factors. This review updates the BD in point of epidemiology, clinical symptoms, diagnosis, prognosis and etiopathology.

Özet

Behçet Hastalığı (BH) ilk olarak 1937 yılında Türk Dermatolog Hulusi Behçet (1889-1948) tarafından tanımlanan kronik vasküler- enflamatuar multisistemik bir hastalıktır. Oto-immün olduğu düşünülen hastalık, ataklarla seyreden oral ve genital aftlar, artrit, kutanöz lezyonlar, göz lezyonları, gastrointestinal sistem ve merkezi sinir sistem tutulumuyla karakterizedir. BH’nin etyolojisi günümüzde hala bilinmemekle birlikte olası etyolojik faktörler arasında enfeksiyöz, psikolojik, genetik ve immünolojik faktörler sayılabilmektedir. Bu derleme BH’yi epidemiyolojik, klinik belirtiler, diagnoz, prognoz ve etyopatogenetik bakımdan güncellemektedir.Anahtar Kelimeler: Behçet hastalığı, epidemiyoloji, etyopatogenez

🔖

Cite This Article

AYTUĞAR, E., PEKİNER, F. N. (2014). Behçet’s disease. Clinical and Experimental Health Sciences, Cilt: 1 - Sayı: 1, 65–73. https://ajindex.com/articles/481894

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Scully C, Gorsky M, Lozada-Nur F: The Diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003; 134: 200-207. Evereklioglu C: Current concepts in the etiology and treatment of Behcet disease. Surv Ophthalmol 2005;50:297-350.
  2. Karlidag R, Unal S, Evereklioglu C, Sipahi B, Er H, Yologlu S. Stressful life events, anxiety, depression and coping mechanisms in patients with Behcet’s disease. J Eur Acad Dermatol Venereol 2003;17:670-675.
  3. Al-Otaibi LM, Porte SR, Poite TWJ: Behçet’s Disease: A Review. J Dent Res, 2005; 84: 209-222.
  4. Pamuk ÖN, Çakır N. Behçet hastalığı epidemiyolojisi. T Klin J Int Med Sci 2005;1:3-9.
  5. Rhee SH, Kim YB, Lee ES: Comparison of Behçet’s Disease and Recurrent Aphthous Ulcer According to Characteristics of Gastrointestinal Symptoms. J Korean Med Sci 2005; 20; 971-976.
  6. Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Chams C, Chams H, Mansoori P, Nadji A: Classification tree for the diagnosis of Behcet’s disease. In: Wechsler B, Godeau P (eds): Behcet’s disease. Excerpta Medica. Amsterdam, 1993; 245-248.
  7. Cakir N, Dervis E, Benian O: Prevalence of Behcet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 2004; 22: 53-5.
  8. Kotake S, Namba K, Higashi K: The change of clinical manifestations of patients with Behcet’s disease in Japan. Adv Exp Med Biol 2003; 528:83-84.
  9. Saylan T, Mat C, Fresko I, Melikoğlu M: Behçet’s disease in the Middle East. Clinics in Dermatology 1999; 17: 209-223. Al-Dalaan AN, al Balaa SR, el Ramahi K, al-Kawi Z, Bohlega S, Bahabri S, al Janadi MA. Behçet’s disease in Saudi Arabia. J Rheumatol. 1994;21:658-61.
  10. Al-Fahad SA, Al-Araji AH: Neuro-Behcet’s disease in Iraq: a study of 40 patients. Journal of the Neurological Sciences, 1999; 170: 105-111. Marshall SE: Behçet’s disease. Best Practice & Research Clinical Rheumatology 2004;18: 291-311.
  11. Demirhindi O, Yazıcı H, Binyıldız P, ve ark. Silivri fener köyü ve yöresinde Behçet hastalığı sıklığı ve bu hastalığın toplum içinde taranmasında kullanılabilecek bir yöntem. Cerrahp Tıp Fak Derg. 1981;12:509-514.
  12. Yurdakul S, Yazici H, Tuzun Y, ve ark. THA arthritis of Behcet’s disease: a prospective study. Ann Rheum Dis 1983; 42: 505-515.
  13. Gul A, Inanc M, Ocal L: Familial aggregation of Behcet’s disease in Turkey. Ann Rheum Dis 2000; 59:622-625.
  14. Yazici H, Fresko I, Tunc R: Behcet’s syndrome: pathogenesis, clinical manifestations and treatment in Vasculitis by Gene V. Ball, S. Louis Bridges ed. Oxford University Press,